Clinical Trial Update: Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating sympathetic nervous system inhibition for diabetic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathies

Snippet

Sponsor: Baker Heart and Diabetes Institute | Conditions: Diabetic Nephropathies | Phase 4 | Status: COMPLETED